Literature DB >> 12680191

Alkylphospholipids reversibly open epithelial tight junctions.

Ancy Leroy1, Georges K P de Bruyne, Lauran C J M Oomen, Marc M Mareel.   

Abstract

Alkylphospholipids, such as the antitumor ether lipid 1-O-octadecyl-2-O-methylglycero-3-phosphocholine, modulate cancer cell invasion through changes in the adherens junction E-cadherin complex, a major organizer of epithelia. We wanted to know whether alkylphospholipids would also change tight junctions, molecular complexes that seal cell-to-cell contacts in polarised epithelia. Therefore, human colorectal cancer cell layers T84 were established in two-compartment culture chambers and the functional integrity of tight junctions was evaluated through their transepithelial electrical resistance. Incorporation of alkylphospholipids causes a rapid and reversible decrease of transepithelial electrical resistance. This decrease is due to an increased paracellular permeability and is temperature-independent. Unlike methyl-beta-cyclodextrin, alkyl-phospholipids do not specifically displace lipids from raft-like membrane domains. Nevertheless, alkylphospholipids change the detergent-solubility of zonula occludens-protein and occludin. Our data, together with the literature, indicate that non-toxic doses of alkylphospholipids affect more than one cell-cell adhesion complex, probably through their incorporation into the plasma membrane lipid bilayer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12680191

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

1.  Intestinal absorption of miltefosine: contribution of passive paracellular transport.

Authors:  Cécile Ménez; Marion Buyse; Christophe Dugave; Robert Farinotti; Gillian Barratt
Journal:  Pharm Res       Date:  2007-03       Impact factor: 4.200

Review 2.  Minireview: Steroid/nuclear receptor-regulated dynamics of occluding and anchoring junctions.

Authors:  Gary L Firestone; Bhumika J Kapadia
Journal:  Mol Endocrinol       Date:  2014-09-09

3.  Phase II study of perifosine in previously untreated patients with metastatic melanoma.

Authors:  D Scott Ernst; Elizabeth Eisenhauer; Nancy Wainman; Mary Davis; Reinhard Lohmann; Tara Baetz; Karl Belanger; Michael Smylie
Journal:  Invest New Drugs       Date:  2005-12       Impact factor: 3.850

Review 4.  A lipid-protein hybrid model for tight junction.

Authors:  David B N Lee; Nora Jamgotchian; Suni G Allen; Michael B Abeles; Harry J Ward
Journal:  Am J Physiol Renal Physiol       Date:  2008-08-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.